- The administration slashes $4B by capping indirect research costs at 15%, impacting labs and staff.
- Scientists warn of halted research, while Democrats call the move illegal and plan lawsuits.
- Elon Musk supports the cuts, but opponents fear harm to U.S. scientific progress.
In a seismic policy shift, the Trump administration has moved to cut billions in indirect funding for biomedical research. This is a decision that scientists and lawmakers alike warn could devastate America's medical innovation and even violate federal law.
The National Institutes of Health (NIH) announced Friday that it would cap indirect cost reimbursements for research grants at 15%, down from an average of 30%, effectively slashing $4 billion annually from critical research infrastructure.
The cuts, effective immediately, will impact essential costs like lab maintenance, utilities, and staff salaries.
Elon Musk, now leading the so-called Department of Government Efficiency (Doge), defended the cuts, accusing universities of siphoning research funds for unnecessary overhead.
“Can you believe that universities with tens of billions in endowments were siphoning off 60% of research award money for ‘overhead’?” Musk wrote on X.
However, researchers argue that these funds sustain the very facilities where breakthroughs occur.
“This would be a devastating hit even for institutions with large endowments,” warned Dr. Anusha Kalbasi, a lead radiation oncologist at Stanford.
The backlash has been swift. Leading Democrats, including Rep. Rosa DeLauro, argue the move directly violates an existing appropriations law that prohibits capping indirect research costs.
Lawsuits are already being prepared, with opponents warning that the cuts will cripple vital medical research and undermine America’s global scientific leadership.
The battle lines are drawn, and the fight for the future of American biomedical research is just beginning.
Edited by Harshajit Sarmah
